Nachrichten zur Bristol-Myers Squibb Co Aktie

Bristol Myers Squibb (BMY) Stock Moves -0.26%: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $64.72, moving -0.26% from the previous trading session....…

Brain Tumor Therapeutics Market to Record 9.10% Y-O-Y Growth Rate in 2021 | Amgen Inc. and Bristol-Myers Squibb Co. Among Key Vendors | Technavio

NEW YORK, Jan. 19, 2022 /PRNewswire/ -- Brain Tumor Therapeutics Market Facts at a Glance- Total Pages: 120 Companies: 10+…

Bristol-Myers Targeted by Senior Democrat on Offshore Tax Deal

Bristol-Myers Targeted by Senior Democrat on Offshore Tax Deal...…

Bristol Myers Squibb Looks Strong In 2022, Century Deal Can Help Establish Cell Therapy Leadership

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Prellis, Bristol Myers Squibb collaborate to discover antibodies

As part of the collaboration, the companies will use Prellis Biologics externalised human immune system (EXIS) which is based on…

Bristol-Myers Squibb (BMY) Presents At 40th Annual J.P. Morgan Healthcare Conference

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum

2seventy bio Incs (NASDAQ: TSVT) anti-BCMA CAR-T got axed as part of a corporate update. read more...…

Evotec kooperiert stärker mit Bristol-Myers Squibb

Um den gesamten Artikel unter boersen-zeitung.de zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb Shares Are Still Undervalued

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Evotec erweitert seine Neurologie-Kooperation mit Bristol Myers Squibb - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Evotec-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…

Evotec Gets $15 Mln From Bristol Myers Squibb On Expansion Of Neuroscience Collaboration

NEW YORK CITY (dpa-AFX) - Evotec AG (EVTCY.PK), a drug discovery and development company, announced Tuesday that it has expanded…

Evotec baut Neurologie-Kooperation mit Bristol Myers aus

FRANKFURT (Dow Jones)--Das Biotechunternehmen Evotec weitet seine Neurologie-Kooperation mit Bristol Myers Squibb aus. Evotec bekomme dafür von Bristol Myers Squibb…

BioAtla collaborates with Bristol Myers Squibb for lead assets

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

This is the time to buy Bristol Myers, says Jim Lebenthal

Jim Lebenthal, Cerity Partners chief equity strategist, and Joe Terranova, Virtus Investment Partners senior managing partner, join the 'Halftime Report'…

We have an accelerated opportunity to renew our portfolio, says Bristol Myers Squibb CEO

Dr. Giovanni Caforio, Bristol Myers Squibb CEO, joins the 'Halftime Report' to discuss his company's collaboration with Century Therapeutics....…

Bristol Myers Squibb Shares Jump After J.P. Morgan Healthcare Conference Presentation

Bristol Myers Squibb Co (NYSE: BMY) kicked off the Big Pharma presentations at the J.P. Morgan healthcare conference. read more...…

Why Bristol-Myers Squibb Shares Are Trading Higher Today

Bristol-Myers Squibb Co (NYSE: BMY) is trading higher Monday after the company announced a $5 billion buyback and issued FY22 financial…

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Crossed Above the 20-Day Moving Average: What That Means for Investors

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?...…

Century Therapeutics Shares Rise 12% Premarket After Bristol Myers Deal

Century Therapeutics Shares Rise 12% Premarket After Bristol Myers Deal...…

Bristol Myers sees slight 2022 sales growth due to sharply lower Revlimid sales

...By Michael Erman Jan 10 (Reuters) - Bristol Myers Squibb Co said......…

Pharmaindustrie: Im Schatten der Pandemie: Wie der Onkologie-Marktführer Millionen von Krebspatienten Hoffnung gibt

Die Zahl an Krebskranken steigt stetig. Der Pharmakonzern Bristol-Myers Squibb auf neue Therapien, Biotech-Allianzen und Zukäufe gegen die Krankheit....…

Pharmaindustrie: Im Schatten der Pandemie: Wie der Onkologie-Weltmarktführer Millionen Krebspatienten Hoffnung gibt

Die Zahl an Krebskranken steigt stetig. Der Pharmakonzern Bristol-Myers Squibb auf neue Therapien, Biotech-Allianzen und Zukäufe gegen die Krankheit....…

Bristol Myers Deal Hunter Sees Divide Over What Assets Are Worth

Bristol Myers Deal Hunter Sees Divide Over What Assets Are Worth...…

Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

Bristol Myers Squibb (BMY) closed at $61.48 in the latest trading session, marking a -1.09% move from the prior day....…

XETR : DIVIDEND/INTEREST INFORMATION - 06.01.2022

Das Instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY wird ex Dividende/Zinsen gehandelt am 06.01.2022 The instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY has…

Bristol Myers Squibb entscheidet sich für ZS zur Optimierung der globalen Vermarktung und der Analysekapazitäten

EVANSTON, Illinois, USA--(BUSINESS WIRE)--Das weltweit tätige Dienstleistungsunternehmen ZS wurde vom marktführenden biopharmazeutischen Unternehmen Bristol Myers Squibb (BMS) (NYSE: BMY) ausgewählt,…

This Big Pharma Stock Is Enriching Shareholders With Its Dividend. But Is It a Buy?

Bristol Myers Squibb is rewarding its shareholders with a huge dividend hike and a massive share-buyback program....…

Bristol-Myers Squibb Vs. Merck Stock: Which Is The Better Buy?

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin

The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin...…

Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $62.35, moving +0.1% from the previous trading session....…

Top Research Reports for salesforce, Intuit & Bristol-Myers

Todays Research Daily features new research reports on 16 major stocks, including salesforce.com, inc. (CRM), Intuit Inc. (INTU), and Bristol-Myers…

CD47 Targeting Therapeutics Market Global Forecasts, 2021-2035, Featuring Abpro, Apmonia Therapeutics, Bristol Myers Squibb, ImmuneOncia Therapeutics and KAHR Medical

DUBLIN, Dec. 24, 2021 /PRNewswire/ -- The "CD47 Targeting Therapeutics Market by Target Disease Indication, Type of Molecule Key Players…

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol Myers Squibb (BMY) closed at $61.45 in the latest trading session, marking a -0.44% move from the prior day....…

Bristol Myers Squibb Stock: Bull vs. Bear

The next few years might be hard for shareholders expecting outperformance....…

Bristol Myers Squibb signs deal with Immatics for solid tumour drug

Bristol Myers Squibb has signed a license, development, and commercialisation agreement with clinical-stage biopharmaceutical firm Immatics for the latter’s TCR…

Hot Stocks heute: Die Zukunft bei Block (ex Square) und Forschungserfolge bei Immatics

Heute geht es um die Zukunft bei Block (ex Square) und der Pharmariese Bristol-Myers Squibb sichert sich erste Forschungserfolge von…

Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know

In the latest trading session, Bristol Myers Squibb (BMY) closed at $59.51, marking a +0.78% move from the previous day....…

Bristol Myers deal propels Immatics more than 10%, most in seven months

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Final Trades: Darden Restaurants, Bristol-Myers, Berkshire Hathaway & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Bristol-Myers (BMY) Up on Dividend Hike, Share Repurchase

Bristol-Myers (BMY) increases its quarterly dividend and announces a share repurchase program. Consequently, the stock gains....…

Bristol-Myers Signs Cancer Deal With German Biotech Immatics

Bristol-Myers Signs Cancer Deal With German Biotech Immatics...…

Immatics: Top-Deal mit keinem geringeren als den Biopharma-Riesen Bristol-Myers Squibb! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Immatics-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Bristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX

Bristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX...…

Bristol Myers enters up to $920 million deal with Immatics for cancer drug

...(Reuters) - Drugmaker Bristol Myers Squibb has agreed to spend up......…

BREAKING: AKTIONÄR-Hot-Stock Immatics: Top-Deal mit Bristol-Myers Squibb

Top-Deal für die in Tübingen ansässige Biotech-Schmiede Immatics: Das Unternehmen konnte eine weltweite Exklusivlizenz für das bispezifische TCR-Programm IMA401 mit…

Cancer Immunotherapy Market to grow by USD 74.45 bn at a CAGR of 14.67% | Evolving Opportunities with Amgen Inc., Bayer AG & Bristol-Myers Squibb Co. | 17000+ Technavio Reports

NEW YORK, Dec. 14, 2021 /PRNewswire/ -- Technavios latest research report on the Cancer Immunotherapy Market offers a comprehensive analysis…